Robbins Andrew R 4
4 · Harpoon Therapeutics, Inc. · Filed May 7, 2021
Insider Transaction Report
Form 4
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 totalExercise: $22.50Exp: 2031-05-03→ Common Stock (10,167 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.